Filters: First Letter Of Last Name is P [Clear All Filters]
Network modeling links breast cancer susceptibility and centrosome dysfunction. Nature genetics. 2007;39(11):1338-49.
Molecular characterization of a t(9;12)(p21;q13) balanced chromosome translocation in combination with integrative genomics analysis identifies C9orf14 as a candidate tumor-suppressor. Genes, chromosomes & cancer. 2007;46(2):155-62.
Trends in socioeconomic inequalities in cancer mortality in Barcelona: 1992-2003. BMC public health. 2009;9:35.
Indoor air pollution caused by cigarette smoke in public places in Portugal . Revista de saude publica. 2007;41(5):808-13.
Exocrine pancreatic cancer clinical factors were related to timing of blood extraction and influenced serum concentrations of lipids. Journal of clinical epidemiology. 2008;61(7):695-704.
Trends in citations to books on epidemiological and statistical methods in the biomedical literature. PloS one. 2013;8(5):e61837.
"Omics" research, monetization of intellectual property and fragmentation of knowledge: can clinical epidemiology strengthen integrative research? Journal of clinical epidemiology. 2007;60(12):1220-5; discussion 1226-8.
Cigarette smoking and K-ras mutations in pancreas, lung and colorectal adenocarcinomas: etiopathogenic similarities, differences and paradoxes. Mutation research. 2009;682(2-3):83-93.
Adult weight gain, fat distribution and mammographic density in Spanish pre- and post-menopausal women (DDM-Spain). Breast cancer research and treatment. 2012.
Meta-analysis of new genome-wide association studies of colorectal cancer risk. Human genetics. 2012;131(2):217-34.
Lessons learnt from a population-based pilot programme for colorectal cancer screening in Catalonia (Spain). Journal of medical screening. 2007;14(2):81-6.
Questionnaire-based second-hand smoke assessment in adults. European journal of public health. 2012.
Women's features and inter-/intra-rater agreement on mammographic density assessment in full-field digital mammograms (DDM-SPAIN). Breast cancer research and treatment. 2012;132(1):287-95.
Interval from diagnosis to treatment onset for six major cancers in Catalonia, Spain. Cancer detection and prevention. 2008;32(3):267-75.
Clinical validity of detecting K-ras mutations for the diagnosis of exocrine pancreatic cancer: a prospective study in a clinically-relevant spectrum of patients. European Journal of Epidemiology. 2011;26(3):229-36.
Pharmacogenetic prediction of clinical outcome in advanced colorectal cancer patients receiving oxaliplatin/5-fluorouracil as first-line chemotherapy. British journal of cancer. 2008;99(7):1050-5.
Absence of large intragenic rearrangements in the DPYD gene in a large cohort of colorectal cancer patients treated with 5-FU-based chemotherapy. British journal of clinical pharmacology. 2010;70(2):268-72.
Methylenetetrahydrofolate reductase gene polymorphisms: genomic predictors of clinical response to fluoropyrimidine-based chemotherapy in females. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2008;26(20):3468; author reply 3468-9.
Pharmacogenetic study in rectal cancer patients treated with preoperative chemoradiotherapy: polymorphisms in thymidylate synthase, epidermal growth factor receptor, GSTP1, and DNA repair genes. International journal of radiation oncology, biology, physics. 2011;81(5):1319-27.
Thymidylate synthase germline polymorphisms in rectal cancer patients treated with neoadjuvant chemoradiotherapy based on 5-fluorouracil. Journal of cancer research and clinical oncology. 2010;136(11):1681-9.